BCK Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

BCK Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,000	Closed	-$1.45M	–	98
2025 Q1	$1.45M	Buy	+11,000	New	+$1.37M	1.13%	22

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BCK Capital Management's ITCI Position: Q2 2025 in Review

BCK Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 11,000 shares — an estimated $1.45M sold.

BCK Capital Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $1.45M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

BCK Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
BCK Capital Management sold 11,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.45M.
BCK Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
BCK Capital Management's Intra-Cellular Therapies Inc. position peaked at $1.45M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on BCK Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.